On June 22nd, The Atlantic hosted its Health Equity Summit, which focused on what the health care system is doing to combat inequities across race, age and gender to improve health outcomes for all Americans.

As part of this event, Amgen held a conversation to explore diversity in clinical trials and how to break down barriers and increase participation in cancer clinical trials among historically underrepresented communities.

Watch as Dr. Ponda Motsepe-Ditshego, global executive medical platform lead, Bone & Nephrology at Amgen and Dr. Marya Shegog, Health Equity and Diversity Coordinator at the Lazarex Cancer Foundation discuss the strides made to increase representation and the work that still needs to be done to help address barriers to greater diversity.

Find out more about Amgen:
[ Ссылка ]

Find Amgen on the Web:
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]

свернуть